featured
Duration of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
N. Engl. J. Med 2021 Jul 29;385(5)395-405, M Gnant, F Fitzal, G Rinnerthaler, GG Steger, S Greil-Ressler, M Balic, D Heck, R Jakesz, J Thaler, D Egle, D Manfreda, V Bjelic-Radisic, U Wieder, CF Singer, E Melbinger-Zeinitzer, F Haslbauer, P Sevelda, H Trapl, V Wette, K Wimmer, SP Gampenrieder, R Bartsch, S Kacerovsky-Strobl, C Suppan, C Brunner, C Deutschmann, L Soelkner, C Fesl, R GreilFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.